Remove Compounding Remove Dosage Remove FDA Remove Vaccines
article thumbnail

How can the pharma industry navigate issues in the global supply chain to minimise drug shortages?

pharmaphorum

Supply chain challenges are compounded by the broader global picture, such as the war in Ukraine, the great resignation, and natural disasters. That means maintaining regulatory readiness – because having cGMP compliance problems with the FDA can significantly exacerbate the problem. It can be done, of course, but it is costly.

FDA 110
article thumbnail

Evolving trends in biological drug delivery: a glimpse into the future

Hospital Pharmacy Europe

Notably, 50% of the new drugs approved by the FDA in 2022 were biologics , underscoring the magnitude of this transformation. This is because biologics tend to be much larger compounds, which are harder to absorb in the gut. Dosage is also an issue when it comes to delivery via inhalation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

Identification and Analysis of Contamination Trends Three major recall databases—those of the US FDA, the United Kingdom’s Medicine and Healthcare Products Regulatory Agency (UK MHRA), and Australia’s Therapeutic Goods Administration (TGA)—were searched to assess contamination trends in the past five years.

article thumbnail

Tamiflu alternatives: What can I take instead of Tamiflu?

The Checkup by Singlecare

Besides the flu vaccine , which remains the best bet for the prevention of influenza and its complications , the other top way to fight back is the drug Tamiflu , an antiviral pill. Pharmacists can even compound a liquid form if needed using capsules. Two older adamantane antiviral drugs are also still in the picture. Savings options.

Dosage 52
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. POD is suitable for a wide range of products, including oral solid dosage forms, mAbs, and cell therapy.

article thumbnail

Regulatory Landscape for Raw Materials: CMC Considerations

ISPE

With shortages, regulatory complexity is compounded due to differences in submission and data requirements from various regulatory agencies. Recent US FDA data show that the lack of raw material availability contributes to 27% of drug shortages (see Appendix ). It is considered a moderate change by the FDA (CBE30) and NMPA.